HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6- (2- (1- (1- (3- ethyl- 3- hydroxypentyloxy)ethyl)- 7- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)spiro(2.5)octane- 4,8- diol

a vitamin D receptor modulator; structure in first source

Also Known As:

VS-110

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Secosteroids: 22
      - 6-(2-(1-(1-(3-ethyl-3-hydroxypentyloxy)ethyl)-7-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)spiro(2.5)octane-4,8-diol: 1

Experts

1.	Chen, Yung-wu: 1 article (01/2013)
2.	Huang, Ching-jang: 1 article (01/2013)
3.	Kawai, Megumi: 1 article (01/2013)
4.	Nakane, Masaki: 1 article (01/2013)
5.	Wessale, Jerry L: 1 article (01/2013)
6.	Wu, Meng-ting: 1 article (01/2013)
7.	Wu-Wong, J Ruth: 1 article (01/2013)

Related Diseases

1.	Hypercalcemia (Milk Alkali Syndrome) 01/01/2013 - "VS-110 improved endothelium-dependent aortic relaxation in a dose-dependent manner and significantly reduced left ventricular fibrosis without affecting serum Ca. VS-411 also exhibited effects on the CV parameters, but was less potent at the high doses with severe hypercalcemia. "
2.	Fibrosis (Cirrhosis) 01/01/2013 - "VS-110 improved endothelium-dependent aortic relaxation in a dose-dependent manner and significantly reduced left ventricular fibrosis without affecting serum Ca. VS-411 also exhibited effects on the CV parameters, but was less potent at the high doses with severe hypercalcemia. "